Reconsidering combined antiplatelet and anticoagulant therapy in atrial fibrillation

Journal of the American College of Cardiology

Volumn 44, Issue 8, 2004, Pages 1567-1569

  Falk, Rodney H ^a  

^a HARVARD VANGUARD MEDICAL ASSOCIATES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; COUMARIN; TRIFLUSAL; WARFARIN;

BLEEDING; BRAIN HEMORRHAGE; CARDIOVASCULAR RISK; CLINICAL TRIAL; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM FIBRILLATION; HEART DISEASE; HUMAN; NOTE; PRIORITY JOURNAL; STROKE;

EID: 5644255760     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.07.026     Document Type: Editorial

References (15)

1. P. Petersen, G. Boysen, J. Godtfredsen, E.D. Andersen, B. Andersen Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation The Copenhagen AFASAK study Lancet 1 1989 175 179
2. A. Laupacis, G. Boysen, S Connolly Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation - analysis of pooled data from five randomized controlled trials Arch Intern Med 154 1994 1449 1457
3. J.L. Blackshear, V.S. Baker, F Rubino Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation - Stroke Prevention in Atrial Fibrillation III randomised clinical trial Lancet 348 1996 633 638
4. E.M. Hylek, S.J. Skates, M.A. Sheehan, D.E. Singer An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation N Engl J Med 335 1996 540 546
5. Pérez-Gómez F, Alegría E, Berjón J, et al. Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study. J Am Coll Cardiol 2004;44:1557-66.
6. D. Massel, S.H. Little Risks and benefits of adding anti-platelet therapy to warfarin among patients with prosthetic heart valves: a meta-analysis J Am Coll Cardiol 37 2001 569 578
7. W. McNeely, K.L. Goa Triflusal Drugs 55 1998 823 833 ; discussion 834-5.
8. A.M. Culebras, R.M. Rotta-Escalante, J.M Vila Triflusal vs aspirin for prevention of cerebral infarction: a randomized stroke study Neurology 62 2004 1073 1080
9. J. Matias-Guiu, J.M. Ferro, J Alvarez-Sabin Comparison of triflusal and aspirin for prevention of vascular events in patients after cerebral infarction: the TACIP study: a randomized, double-blind, multicenter trial Stroke 34 2003 840 848
10. J.M. Cruz-Fernandez, L. Lopez-Bescos, D Garcia-Dorado Randomized comparative trial of triflusal and aspirin following acute myocardial infarction Eur Heart J 21 2000 457 465
11. A. Lanas, P. Serrano, E. Bajador, J. Fuentes, R. Sainz Risk of upper gastrointestinal bleeding associated with non-aspirin cardiovascular drugs, analgesics and nonsteroidal anti-inflammatory drugs Eur J Gastroenterol Hepatol 15 2003 173 178
12. V. Pengo, F. Barbero, A. Biasiolo, C. Pegoraro, F. Noventa, S. Iliceto Prevention of thromboembolism in patients with mitral stenosis and associated atrial fibrillation: effectiveness of low intensity (INR target 2) oral anticoagulant treatment Thromb Haemost 89 2003 760 764
13. D.B. Salem, D.H. Daudelin, H.J. Levine, S.G. Pauker, M.H. Eckman, J. Riff Antithrombotic therapy in valvular heart disease Chest 119 2001 207S-19S
14. M. Hurlen, M. Abelnoor, P. Smith, J. Erikssen, H. Arnesen Warfarin, aspirin, or both after myocardial infarction N Engl J Med 347 2002 969 974
15. European Atrial Fibrillation Trial Study Group Investigators Secondary prevention in non-rheumatic atrial fibrillation after transient ischemic attack or minor stroke Lancet 342 1993 1255 1262